Unichem Laboratories Limited announced that it has received ANDA approval for its Metformin Hydrochloride Extended-Release Tablets USP, 500 mg and 750 mg from the United States Food and Drug Administration (USFDA) to market a generic version of Glucophage XR Tablets, 500 mg and 750 mg, of EMD Serono Inc.
Metformin Hydrochloride Extended-Release Tablets are indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus.
The product will be commercialized from Unichem’s Goa Plant.
At around 2.24 pm, Unichem was trading at Rs292.30 per piece down by 2.7% on Sensex.